이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+ (GLB-SCI+)

2022년 3월 7일 업데이트: Baylor Research Institute
This study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. The approach is to obtain data on the 3 unique strategies (prepackaged/portion-controlled meals; enhanced self-monitoring; the GLB-SCI) to inform design of an empirically supported and consumer-validated multicomponent intervention program, that combines the best of the 3 approaches into one unique intervention, the GLB SCI+. Based on the investigators' prior experience with adapting and delivering the GLB AIM (a lifestyle intervention previously adapted for those with impaired mobility), interim findings, existing literature, and consumer feedback, they hypothesize that these 3 unique strategies may confer individualized benefits to people with SCI given their complex disability-related barriers to weight loss.

연구 개요

연구 유형

중재적

등록 (예상)

128

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Texas
      • Dallas, Texas, 미국, 75246
        • Baylor Scott & White Institute for Rehabilitation - Dallas

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Over 18 years old
  • Have had a spinal cord injury for at least 1 year
  • Overweight as evidenced by BMI > 25
  • Must have sufficient upper arm mobility to engage in exercise
  • Must have access to the internet
  • Must be able to obtain physician signed clearance to participate in a weight management intervention

Exclusion Criteria:

  • Cognitive impairment which substantially impairs autonomy (e.g. mental retardation)
  • Medical issues for which exercise is contraindicated such as uncontrolled hypertension or coronary heart disease,
  • Pregnancy
  • Not fluent in English
  • Presence of grade 3 or 4 pressure ulcer
  • Previously diagnosed eating disorder

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 지지 요법
  • 할당: 무작위화되지 않음
  • 중재 모델: 순차적 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Portion-Controlled Meals
Participants will receive prepackaged food, delivered biweekly to their home over the course of 13 weeks, with costs covered by the grant. Depending on their calorie goals, participants will drink and eat a mix of shakes and entrees each day, plus up to five fruits and vegetables. HMR entrees and shakes are formulated to provide recommended levels of macronutrients, vitamins, sodium, fat, cholesterol and fiber and fortified to meet at least 100% of the recommended daily allowance for essential vitamins and minerals.
Participants will receive portion-controlled meals with the aim of encouraging weight loss and healthier eating.
실험적: Enhanced Self-Monitoring
Participants will be encouraged to self-monitor 4 specific behaviors daily: 1) measuring their food; 2) measuring their physical activity; 3) recording their food, drink, and physical activity; and 4) monitoring their weight. To achieve this aim, participants will attend a single group-based educational session at baseline during which they will be provided the self-monitoring equipment (scale and Garmin vivofit) and receive training about how to use the Lilypad scale and smartphone food tracking app.
Participants will be encouraged to track their physical activity, food intake, and weight using technology that will be provided as part of the study.
실험적: GLB-SCI
The content and delivery format of the developed GLB SCI lifestyle intervention program is subject to change based on guidance of the SCI Consumer Group. Therefore, this section provides a general description of the GLB AIM (lifestyle intervention program adapted for impaired mobility). The content of the GLB AIM core meetings include a mix of in-person (4) and telephone (9) sessions. The initial meeting is conducted in person, with one in-person sessions delivered each month, and the intervening weeks delivered by telephone. To achieve weight loss, participants will be encouraged to follow daily calorie and fat gram goals to achieve a .5 to 1 pound weight loss over the 13 weeks. Participants will also be encouraged to gradually increase their physical activity to ultimately achieve 150 weekly minutes.
Participants will take part in a lifestyle intervention program (tailored for spinal cord injury needs) that encourages steady weight loss through increased physical activity and healthier diet patterns.
실험적: GLB-SCI+
The final multicomponent GLB SCI+ will include combining specific intervention strategies identified from the previous 3 interventions as effective and usable. If all 3 strategies yield evidence in support of being included, the combined intervention would encompass (1) providing prepackaged foods for a specified period of time to facilitate greater initial weight loss, (2) encouraging enhanced self-monitoring of food, physical activity, and weight using devices and apps along with social support, and (3) delivering the further adapted GLB SCI in a group-based format to teach skills helpful in making lifestyle changes.
Participants will receive a combination of the prior interventions studied, with the goal of showing that a multi-component intervention will be the most effective in encouraging weight loss among participants with a spinal cord injury.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change in weight
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Change in weight (pounds) will be measured after each 13-week intervention.
Approximately every 13 weeks through study completion, expected to be 3 years.
Change in physical activity level
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Change in self-reported physical activity (minutes per week) will be measured after each 13-week intervention to assess whether the intervention effectively encouraged greater levels of physical activity.
Approximately every 13 weeks through study completion, expected to be 3 years.
Self-efficacy
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Self-efficacy will be measured through changes in the Self-Rated Abilities for Health Practices Scale from baseline to post-intervention. The questionnaire contains 28 items that are on a 5-point scale. It was designed to measure a person's perception of his/her own ability to practice "healthy" behaviors and has 4 sub-scales with 7 items each: Exercise, Nutrition, Responsible Health Practice, and Psychological Well Being. Ratings for each subscale are summed to yield subscale scores and subscale scores are summed to obtain a total score. Higher scores indicate greater confidence in one's ability to perform health practices and total scores range from 0-112.
Approximately every 13 weeks through study completion, expected to be 3 years.
Function/Quality of Life
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Changes in self-reported levels of function and quality of life will be assessed through the LIFE-H survey, given before and after each intervention. The Assessment of Life Habits (LIFE-H) assesses a person's self-reported difficulty with and need for assistance performing tasks associated with activities of daily living (ADL) and social roles. The version used for this study covers 6 ADL categories: nutrition, fitness, personal care, communication, residence, mobility and 6 social role categories: responsibility, interpersonal relations, community, education, employment, recreation. Scoring is based on respondent rating of level of accomplishment (No difficulty to Not accomplished) combined with the type of assistance (if any) used to perform these tasks. Scores range from 9 to 0, with higher scores indicating less difficulty.
Approximately every 13 weeks through study completion, expected to be 3 years.

2차 결과 측정

결과 측정
측정값 설명
기간
Change in waist circumference
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their waist circumference measured before and after each intervention to assess the level of change, if any.
Approximately every 13 weeks through study completion, expected to be 3 years.
Change in blood pressure (systolic and diastolic)
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their blood pressure measured before and after each intervention to assess the level of change, if any.
Approximately every 13 weeks through study completion, expected to be 3 years.
Change in hemoglobin A1c level
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their hemoglobin A1c measured before and after each intervention assess the level of change, if any.
Approximately every 13 weeks through study completion, expected to be 3 years.
Change in motivation for weight-loss
기간: Approximately every 13 weeks through study completion, expected to be 3 years.
Participants will have their levels of motivation assessed before and after each intervention with the Treatment Self-Regulation Questionnaire. The 18-item Treatment Self-Regulation Questionnaire is derived from self-determination theory and yields 2 subscales: autonomous regulation (or intrinsic motivation) and controlled regulation (or extrinsic motivation). Responses are provided on a 7-point Likert type scale ranging from 1 'not at all true' to 7 'very true,' and includes the option of "not applicable." Autonomous Regulation scores are obtained by averaging questions 3, 4, 9, 13, 17, 18 and Controlled Regulation scores are obtained by averaging questions 1, 2, 5, 6, 7, 8, 10, 11, 12, 14, 15, 16. Higher scores indicate higher levels of motivation. Higher scores indicate higher levels of each type of regulation.
Approximately every 13 weeks through study completion, expected to be 3 years.

기타 결과 측정

결과 측정
측정값 설명
기간
Group meeting attendance
기간: Attendance will be tracked over the entire 13-week intervention.
Intervention arms involving meeting on a regular basis will have attendance tracked to assess the overall feasibility of the intervention and to examine correlations between self-monitoring and weight-loss.
Attendance will be tracked over the entire 13-week intervention.
Adherence to self-monitoring
기간: Adherence will be tracked over the entire 13-week intervention.
Intervention arms involving self-monitoring food intake and physical activity will have levels of adherence tracked to assess the overall feasibility of the intervention and to examine correlations between self-monitoring and weight-loss.
Adherence will be tracked over the entire 13-week intervention.
Individualized teleconference attendance
기간: Attendance will be tracked over the entire 13-week intervention.
Intervention arms involving teleconference meeting attendance will have levels of adherence tracked to examine correlations between attendance and weight-loss.
Attendance will be tracked over the entire 13-week intervention.
Participant perceptions of each intervention
기간: Perception will be assessed at the end of the 13-week intervention.
Participant perceptions will be assessed using a survey that asks participants to rate on a scale of 1 - 5 each active component used in each study
Perception will be assessed at the end of the 13-week intervention.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2019년 6월 1일

기본 완료 (실제)

2021년 10월 19일

연구 완료 (예상)

2022년 6월 1일

연구 등록 날짜

최초 제출

2019년 2월 7일

QC 기준을 충족하는 최초 제출

2019년 3월 13일

처음 게시됨 (실제)

2019년 3월 14일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2022년 3월 8일

QC 기준을 충족하는 마지막 업데이트 제출

2022년 3월 7일

마지막으로 확인됨

2022년 2월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

IPD 계획 설명

This project will generate data designed to study the feasibility, effectiveness, and usability of several weight-loss strategies in a sample of approximately 100 participants with spinal cord injury. These data will be submitted to Inter-university Consortium for Political and Social Research (ICPSR). ICPSR will make the research data from this project available to the broader social science research community. These files, in which direct and indirect identifiers have been removed to minimize disclosure risk, may be accessed directly through the ICPSR website. After depositing the data, the dissemination will be delayed for one year to allow for the principal investigator and collaborators to complete major manuscripts related to the data. ICPSR will accept responsibility for long-term preservation of the research data upon receipt of a signed deposit form.

IPD 공유 기간

1 year after completion of all study activities. The research data from this project will be deposited with the digital repository of the Inter-university Consortium for Political and Social Research (ICPSR) to ensure that the research community has long-term access to the data.

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

Portion-Controlled Meals에 대한 임상 시험

3
구독하다